Corpus Intelligence IC Memo — HARNETT HEALTH SYSTEM 2026-04-26 09:39 UTC
IC Memo — HARNETT HEALTH SYSTEM
Investment Committee Memorandum | NC | 126 beds | Grade C | EBITDA uplift $9.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HARNETT HEALTH SYSTEM

CCN 340071 | HARNETT, NC | 126 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HARNETT HEALTH SYSTEM is a 126-bed suburban community hospital in HARNETT, NC with $121.7M in net patient revenue and a -8.1% operating margin. The hospital serves a payer mix of 19.4% Medicare, 2.6% Medicaid, and 78.0% commercial.

Thesis: Undervalued. Our ML models identify $9.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.1% to -0.8% (+736bps).

Net Revenue HCRIS$121.7M
Current EBITDA COMPUTED$-9.9M
Operating Margin COMPUTED-8.1%
Occupancy HCRIS60.6%
Revenue / Bed COMPUTED$966K
Net-to-Gross HCRIS26.1%
Distress Probability ML45.0%

2. Market Context & Competitive Position

129
NC Hospitals
-2.0%
State Median Margin
58
Comparable Hospitals

NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of -8.1% places it below the state median. Among 58 size-comparable peers (63-252 beds), the median margin is -1.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (63-252), prioritizing same-state peers. 58 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HARNETT HEALTH SYSTEM (Target)NC126$121.7M-8.1%
DUKE RALEIGH HOSPITALNC186$683.0M3.7%
CATAWBA VALLEY MEDICAL CENTERNC200$451.9M5.9%
MARGARET R. PARDEE MEMORIAL HONC160$341.3M-5.7%
JOHNSTON HEALTHNC179$331.7M9.6%
WAKE MED CARY HOSPITALNC189$318.1M-3.6%
ATRIUM HEALTH UNIONNC183$302.3M7.0%
S.E. REGL MEDICAL CENTERNC179$298.1M-25.3%
WAYNE MEMORIAL HOSPITALNC245$295.1M8.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.6M+210bp18mo
Cost to Collect4.5%2.5%$2.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$78K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.6M
Cost to Collect
$2.4M
Denial Rate Reduction
$2.4M
A/R Days Reduction
$1.5M
Clean Claim Rate
$78K
Total EBITDA Uplift$9.0M
Current EBITDA$-9.9M
+ RCM Uplift+$9.0M
Pro Forma EBITDA$-920K
Current Margin-8.1%
Pro Forma Margin-0.8%
WC Released (1x)$4.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-15.2M$24.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-15.2M$21.9M0.00x-100.0%
Bull Case9.0x11.0x$-13.7M$46.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-13.7M$46.7M0.00x-100.0%
Bear Case11.0x10.0x$-16.7M$-15.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-16.7M$-22.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 58 hospitals with 63-252 beds
  • Same-state prioritization (n=59)
  • Comp margins: P25=-8.0% / P50=-1.3% / P75=7.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.